Table 1.
Treatment | Scaffold | rhNell-1 | Pericytes | n (implants) |
---|---|---|---|---|
Carrier Alone | hCBC (100 μL) | 50 mg TCP alone | None | 8 |
Nell-1 Alone | hCBC (100 μL) | 15 μg Nell-1 in 50 mg TCP | None | 8 |
Pericyte Alone | hCBC (100 μL) | 50 mg TCP alone | 2.5×105 in 20 μL | 8 |
Pericyte+Nell-1 | hCBC (100 μL) | 15 μg Nell-1 in 50 mg TCP | 2.5×105 in 20 μL | 8 |
Pericyte+Nell-1 | hCBC (100 μL) | 100 μg Nell-1 in 50 mg TCP | 2.5×105 in 20 μL | 8 |
Pericyte+Nell-1 | hCBC (100 μL) | 300 μg Nell-1 in 50 mg TCP | 2.5×105 in 20 μL | 8 |
hCBC, human cortical/cancellous bone chip; TCP, tricalcium phosphate.